Valuation GSK plc NYSE

Stocks

Market Closed - NYSE 01:30:02 21/08/2026 am IST			5-day change	1st Jan Change
51.96 ^USD	-1.74%		+2.99%	+5.95%

02:11pm	WINNERS & LOSERS: Hunting falls on outlook cut; miners rise	AN
20/08	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	76,955	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	5.13%	-	-
Enterprise Value (EV) ¹	1,00,296	75,578	74,152	68,039	87,654	96,155	93,328	90,280
Change	-	-24.65%	-1.89%	-8.24%	28.83%	9.7%	-2.94%	-3.27%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	14.5x	11.9x	11.1x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.67x	4.05x	3.54x
PEG	-	0x	-0.2x	-0.4x	0x	-2.32x	0.5x	1.6x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.27x	2.17x	2.1x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.83x	2.63x	2.46x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.38x	7.59x	7.09x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.33x	8.43x	7.81x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	17.3x	16.1x	13.3x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.77%	6.21%	7.53%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7495	0.7831
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.62%	3.9%	4.08%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.323	1.616	1.728
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	52.6%	46.4%	45.3%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,944	35,537	36,668
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,470	12,290	12,729
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,303	11,077	11,553
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,436	6,484	6,933
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	19,200	16,373	13,325
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.20	19.20	19.20
Nbr of stocks (in thousands)	40,06,383	40,60,999	40,76,145	40,80,519	40,12,126	40,07,011	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.55x	12.84x	26.06x	0.55%	1,10900Cr
JOHNSON & JOHNSON	29.74x	-	-	2.01%	64TCr
ABBVIE INC.	33.42x	7.74x	16.11x	2.62%	46TCr
ROCHE HOLDING AG	20.72x	4.91x	12.16x	2.69%	37TCr
NOVARTIS AG	22.47x	5.78x	14.33x	2.76%	30TCr
ASTRAZENECA PLC	21.12x	4.35x	12.35x	2.02%	26TCr
AMGEN INC.	27.43x	7.09x	12.59x	2.33%	23TCr
NOVO NORDISK A/S	13.47x	4.79x	10.05x	3.81%	20TCr
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	18TCr
Average	17.79x	6.73x	16.05x	2.34%	41.79TCr
Weighted average by Cap.	25.34x	8.43x	18.53x	1.91%